Browsing by Author de Klippel, N

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
TitleAuthor(s)???itemlist.dc.contributor.other??????itemlist.dc.contributor.editor???
A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial (vol 261, pg 2101, 2014)Ziemssen, T; Bajenaru, OA; Carra, A; de Klippel, N; de Sa, JC; Edland, A; Frederiksen, JL; Heinzlef, O; Karageorgiou, KE; Delgado, RHL; Landtblom, AM; Islas, MAM; Tubridy, N; Gilgun-Sherki, Y--
A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial (vol 261, pg 2101, 2014)Ziemssen, T; Bajenaru, OA; Carra, A; de Klippel, N; de Sa, JC; Edland, A; Frederiksen, JL; Heinzlef, O; Karageorgiou, KE; Delgado, RHL; Landtblom, AM; Islas, MAM; Tubridy, N; Gilgun-Sherki, Y--
COPTIMIZE: a two-year observational survey of patients with relapsing remitting multiple sclerosis switching to glatiramer acetate 20 mg dailyZiemssen, T; Bajenaru, O; Carra, A; de Klippel, N; de Sa, J; Edland, A; Frederiksen, J; Heinzlef, O; Karageorgiou, K; Landtblom, AM; Islas, MM; Tubridy, N; Gilgun-Sherki, Y--
COPTIMIZE: a two-year observational survey of patients with relapsing remitting multiple sclerosis switching to glatiramer acetate 20 mg dailyZiemssen, T; Bajenaru, O; Carra, A; de Klippel, N; de Sa, J; Edland, A; Frederiksen, J; Heinzlef, O; Karageorgiou, K; Landtblom, AM; Islas, MM; Tubridy, N; Gilgun-Sherki, Y--